ERBB2 and breast cancer: Related studies (31–33) have revealed that the incidence of breast cancer in Xinjiang is marginally lower than that of the entire nation, with the features that Luminal B breast cancer is more prevalent, the proportion of HER-2 overexpression type is lower, and triple-negative breast cancer is more likely to relapse and metastasize in Uygur patients.